Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Retrieved on: 2022-08-15 12:10:51

Tags for this article:

Click the tags to see associated articles and topics

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases. View article details on HISWAI: https://www.bakersfield.com/ap/news/q32-bio-and-horizon-therapeutics-announce-collaboration-in-autoimmune-diseases/article_5fd6a569-c974-5be1-9659-60d14cc44b7b.html

Excerpt

Q32 Bio's lead programs, focused on the IL-7 / TSLP receptor pathways and complement system, address immune dysregulation to help patients take ...

Article found on: www.bakersfield.com

View Original Article